New relevant target for PARP inhibitor talazoparib

Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in enhanced anti-cancer effects.

from Latest Science News -- ScienceDaily https://ift.tt/3fgDUXo